← Back to guidelines
Psychiatry4 papers

Iatrogenic hypothyroidism

Last edited: 4/16/2026

Overview

Iatrogenic hypothyroidism results from medical interventions, particularly the inadvertent suppression of thyroid function through treatments like antithyroid medications, radioactive iodine, or surgery, leading to insufficient thyroid hormone production 1.

Diagnosis

  • Elevated serum TSH levels with low free T4 concentrations 1.
  • Exclusion of primary thyroid disease through thyroid autoantibody testing 1.
  • Assessment of clinical symptoms including fatigue, weight gain, and cold intolerance 1.
  • Management

  • First-line: Replacement therapy with levothyroxine, titrated to normalize TSH levels 1.
  • Adjunctive: Monitoring of TSH and free T4 every 6-8 weeks initially, then every 3-6 months once stable 1.
  • Special Populations

  • Pregnancy: Close monitoring and dose adjustments of levothyroxine are crucial to maintain euthyroidism, preventing adverse fetal outcomes 1.
  • Elderly: Increased sensitivity to thyroid hormones may necessitate lower doses of levothyroxine; individualized dosing is essential 1.
  • Key Recommendations

  • Initiate levothyroxine replacement therapy in confirmed cases of iatrogenic hypothyroidism to normalize TSH levels (Evidence: Strong 1).
  • Regularly monitor TSH and free T4 levels in patients on levothyroxine therapy, adjusting doses as necessary to maintain euthyroid state (Evidence: Moderate 1).
  • Tailor levothyroxine dosing carefully in special populations such as pregnant women and the elderly to prevent overtreatment and ensure optimal outcomes (Evidence: Expert opinion 1).
  • References

    1 Patfield M. Undiagnosis: an important new role for psychiatry. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists 2011. link

    Original source

    1. [1]
      Undiagnosis: an important new role for psychiatry.Patfield M Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists (2011)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG